4.7 Article

Polygenic Risk Scores Predict Hypertension Onset and Cardiovascular Risk

期刊

HYPERTENSION
卷 77, 期 4, 页码 1119-1127

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/HYPERTENSIONAHA.120.16471

关键词

association; blood pressure; cardiovascular diseases; genetics; hypertension; risk factors

资金

  1. Academy of Finland [321351]
  2. Urmas Pekkala Foundation
  3. Paavo Nurmi Foundation
  4. Finnish Foundation for Cardiovascular Research
  5. Finnish Medical Foundation
  6. Emil Aaltonen Foundation
  7. Hospital District of Southwest Finland
  8. Turku University Foundation
  9. University of Turku
  10. National Institutes of Health [R01-HL134168, R01-HL131532, R01-HL143227, R01-HL142983]

向作者/读者索取更多资源

Genetic risk scores can improve the prediction of hypertension risk, especially early-onset hypertension, which is associated with significant cardiovascular disease risk. Combining BP PRS with traditional risk factors can enhance hypertension prediction strategies, as demonstrated in the study.
Although genetic risk scores have been used to predict hypertension, their utility in the clinical setting remains uncertain. Our study comprised N=218 792 FinnGen participants (mean age 58 years, 56% women) and N=22 624 well-phenotyped FINRISK participants (mean age 50 years, 53% women). We used public genome-wide association data to compute polygenic risk scores (PRSs) for systolic and diastolic blood pressure (BP). Using time-to-event analysis, we then assessed (1) the association of BP PRSs with hypertension and cardiovascular disease (CVD) in FinnGen and (2) the improvement in model discrimination when combining BP PRSs with the validated 4- and 10-year clinical risk scores for hypertension and CVD in FINRISK. In FinnGen, compared with having a 20 to 80 percentile range PRS, a PRS in the highest 2.5% conferred 2.3-fold (95% CI, 2.2-2.4) risk of hypertension and 10.6 years (95% CI, 9.9-11.4) earlier hypertension onset. In subgroup analyses, this risk was only 1.6-fold (95% CI, 1.5-1.7) for late-onset hypertension (age >= 55 years) but 2.8-fold (95% CI, 2.6-2.9) for early-onset hypertension (age <55 years). Elevated systolic BP PRS also conferred 1.3-fold (95% CI, 1.2-1.4) risk of CVD and 2.3 years (95% CI, 1.6-3.1) earlier onset. In FINRISK, systolic and diastolic BP PRSs improved clinical risk prediction of hypertension (but not CVD), increasing the C statistics by 0.7% (95% CI, 0.3-1.1). We demonstrate that genetic information improves hypertension risk prediction. BP PRSs together with traditional risk factors could improve prediction of hypertension and particularly early-onset hypertension, which confers substantial CVD risk.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据